{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:14:22Z","timestamp":1761488062839,"version":"3.44.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.ophtha.2008.04.011","type":"journal-article","created":{"date-parts":[[2008,6,6]],"date-time":"2008-06-06T04:30:04Z","timestamp":1212726604000},"page":"1728-1734.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Intraocular Pressure-Lowering Efficacy of Brinzolamide 1%\/Timolol 0.5% Fixed Combination Compared with Brinzolamide 1% and Timolol 0.5%"],"prefix":"10.1016","volume":"115","author":[{"given":"Martin","family":"Kaback","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen V.","family":"Scoper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Arzeno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John E.","family":"James","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven Y.","family":"Hua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig","family":"Salem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaime E.","family":"Dickerson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theresa A.","family":"Landry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael V.W.","family":"Bergamini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2008.04.011_bib1","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0002-9394(00)00538-9","article-title":"The Advanced Glaucoma Intervention Study (AGIS): 7","volume":"130","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2008.04.011_bib2","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/archopht.120.6.701","article-title":"The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma","volume":"120","author":"Kass","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2008.04.011_bib3","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1001\/archopht.1977.04450040067008","article-title":"Timolol: a beta-adrenergic blocking agent for the treatment of glaucoma","volume":"95","author":"Zimmerman","year":"1977","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2008.04.011_bib4","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0161-6420(81)35054-4","article-title":"Timolol: Canadian multicenter study","volume":"88","author":"LeBlanc","year":"1981","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2008.04.011_bib5","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/S0161-6420(83)34380-3","article-title":"The mechanism of betaxolol, a new ocular hypotensive agent","volume":"90","author":"Reiss","year":"1983","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2008.04.011_bib6","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0014-4835(78)90083-0","article-title":"A fluorophotometric study of the effect of topical timolol on aqueous humor dynamics","volume":"27","author":"Yablonski","year":"1978","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.ophtha.2008.04.011_bib7","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1001\/archopht.1978.03910060433007","article-title":"The mechanism of timolol in lowering intraocular pressure: in the normal eye","volume":"96","author":"Coakes","year":"1978","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2008.04.011_bib8","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0039-6257(79)90229-7","article-title":"Experimental studies on the mechanism of action of timolol","volume":"23","author":"Neufeld","year":"1979","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ophtha.2008.04.011_bib9","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/0002-9394(82)90419-6","article-title":"The effects of timolol maleate and acetazolamide on the rate of aqueous formation in normal human subjects","volume":"93","author":"Dailey","year":"1982","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2008.04.011_bib10","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/0039-6257(83)90152-2","article-title":"Laboratory and clinical studies on the mechanism of action of timolol","volume":"28","author":"Neufeld","year":"1983","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ophtha.2008.04.011_bib11","first-page":"776","article-title":"Aqueous humor flow during sleep","volume":"25","author":"Reiss","year":"1984","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2008.04.011_bib12","first-page":"1315","article-title":"Effects of timolol, epinephrine, and acetazolamide on aqueous flow during sleep","volume":"26","author":"Topper","year":"1985","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2008.04.011_bib13","first-page":"2439","article-title":"Elevation of human intraocular pressure at night under moderate illumination","volume":"40","author":"Liu","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2008.04.011_bib14","first-page":"2566","article-title":"Effect of timolol, latanoprost, and dorzolamide on circadian IOP in glaucoma or ocular hypertension","volume":"41","author":"Orzalesi","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2008.04.011_bib15","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ajo.2004.04.022","article-title":"Comparison of the nocturnal effects of once-daily timolol and latanoprost on intraocular pressure","volume":"138","author":"Liu","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2008.04.011_bib16","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/S0161-6420(01)00873-9","article-title":"Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery","volume":"108","author":"Lichter","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2008.04.011_bib17","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1136\/bjo.85.8.962","article-title":"A 7 year prospective comparative study of three topical beta blockers in the management of primary open angle glaucoma","volume":"85","author":"Watson","year":"2001","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2008.04.011_bib18","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1016\/S0161-6420(98)91047-8","article-title":"A randomized trial in patients inadequately controlled with timolol alone comparing the dorzolamide-timolol combination to monotherapy with timolol or dorzolamide","volume":"105","author":"Clineschmidt","year":"1998","journal-title":"Ophthalmology"},{"issue":"suppl","key":"10.1016\/j.ophtha.2008.04.011_bib19","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.1016\/S0039-6257(99)00108-3","article-title":"Preclinical overview of brinzolamide","volume":"44","author":"DeSantis","year":"2000","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ophtha.2008.04.011_bib20","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0002-9394(99)00179-8","article-title":"Effect of brinzolamide and dorzolamide on aqueous humor flow in human eyes","volume":"128","author":"Ingram","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2008.04.011_bib21","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S1350-9462(99)00006-3","article-title":"Pharmacological and ocular hypotensive properties of topical carbonic anhydrase inhibitors","volume":"19","author":"Sugrue","year":"2000","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.ophtha.2008.04.011_bib22","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0002-9394(98)00095-6","article-title":"Clinical efficacy and safety of brinzolamide (Azopt), a new topical carbonic anhydrase inhibitor for primary open-angle glaucoma and ocular hypertension","volume":"126","author":"Silver","year":"1998","journal-title":"Am J Ophthalmol"},{"issue":"suppl","key":"10.1016\/j.ophtha.2008.04.011_bib23","doi-asserted-by":"crossref","first-page":"S163","DOI":"10.1016\/S0039-6257(99)00106-X","article-title":"Adjunctive therapy with brinzolamide 1% ophthalmic suspension (Azopt) in patients with open-angle glaucoma or ocular hypertension maintained on timolol therapy","volume":"44","author":"Shin","year":"2000","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ophtha.2008.04.011_bib24","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0002-9394(01)00974-6","article-title":"Comparison of topical brinzolamide 1% and dorzolamide 2% eye drops given twice daily in addition to timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension","volume":"132","author":"Michaud","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2008.04.011_bib25","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.ophtha.2004.12.026","article-title":"Does adjunctive glaucoma therapy affect adherence to the initial primary therapy?","volume":"112","author":"Robin","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2008.04.011_bib26","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ophtha.2005.10.034","article-title":"Patient-reported behavior and problems in using glaucoma medications","volume":"113","author":"Sleath","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2008.04.011_bib27","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1001\/jama.1989.03420220087032","article-title":"How often is medication taken as prescribed?","volume":"261","author":"Cramer","year":"1989","journal-title":"JAMA"},{"key":"10.1016\/j.ophtha.2008.04.011_bib28","first-page":"277","article-title":"A comparison of patient compliance in treated vs untreated ocular hypertension","volume":"81","author":"Bigger","year":"1976","journal-title":"Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol"},{"key":"10.1016\/j.ophtha.2008.04.011_bib29","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0039-6257(80)90045-4","article-title":"Compliance with ocular therapy","volume":"24","author":"Ashburn","year":"1980","journal-title":"Surv Ophthalmol"},{"issue":"suppl","key":"10.1016\/j.ophtha.2008.04.011_bib30","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/0039-6257(83)90142-X","article-title":"Facilitating patient compliance in glaucoma therapy","volume":"28","author":"Zimmerman","year":"1983","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ophtha.2008.04.011_bib31","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S0002-9394(99)00235-4","article-title":"Cost considerations of medical therapy for glaucoma","volume":"128","author":"Fiscella","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2008.04.011_bib32","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0002-9394(03)00102-8","article-title":"Medical therapy cost considerations for glaucoma","volume":"136","author":"Fiscella","year":"2003","journal-title":"Am J Ophthalmol"},{"issue":"suppl","key":"10.1016\/j.ophtha.2008.04.011_bib33","doi-asserted-by":"crossref","first-page":"S155","DOI":"10.1016\/S0039-6257(99)00107-1","article-title":"The efficacy and safety of brinzolamide 1% ophthalmic suspension (Azopt) as a primary therapy in patients with open-angle glaucoma or ocular hypertension","volume":"44","author":"Sall","year":"2000","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ophtha.2008.04.011_bib34","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/biomet\/75.2.383","article-title":"A stagewise rejective multiple test procedure based on a modified Bonferroni test","volume":"75","author":"Hommel","year":"1988","journal-title":"Biometrika"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642008003709?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642008003709?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:57:00Z","timestamp":1758981420000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642008003709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S0161642008003709"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2008.04.011","relation":{},"ISSN":["0161-6420"],"issn-type":[{"type":"print","value":"0161-6420"}],"subject":[],"published":{"date-parts":[[2008,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intraocular Pressure-Lowering Efficacy of Brinzolamide 1%\/Timolol 0.5% Fixed Combination Compared with Brinzolamide 1% and Timolol 0.5%","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2008.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}